Literature DB >> 17984195

Detection of rheumatoid arthritis bone erosions by two different dedicated extremity MRI units and conventional radiography.

A Duer-Jensen1, A Vestergaard, U M Døhn, B Ejbjerg, M L Hetland, E Albrecht-Beste, M Østergaard.   

Abstract

OBJECTIVES: To compare the ability of two different dedicated extremity MRI (E-MRI) units and conventional radiography (CR) for identifying bone erosions in rheumatoid arthritis (RA) metacarpophalangeal (MCP) and wrist joints.
METHODS: CR and two MRI examinations (using 0.2 T Esaote Artoscan and 0.2 T portable MagneVu MV1000 units) of 418 bones in the dominant wrist and second to fifth MCP joints of 15 patients with RA and 4 healthy controls were performed and evaluated blindly for bones being visible and for erosions.
RESULTS: In MCP joints, MagneVu visualised 18.5% of bones entirely and 71.1% were 67-99% visualised. In wrists, MagneVu visualised 1.5% of bones entirely, 39.8% were 67-99% visualised and 19% were not visualised at all. Artoscan and CR visualised all bones entirely. Artoscan, MagneVu and CR found 22, 19 and 15 bones with erosions in MCP joints and 66, 40 and 13 bones with erosions in wrist joints, respectively. With the previously validated Artoscan unit as standard reference, MagneVu and CR had sensitivities of 0.82 and 0.55, respectively, in MCP joint bones and 0.41 and 0.14 in wrist bones. Specificities of CR and MagneVu were comparable (0.82-0.99). The MagneVu unit was particularly more sensitive than CR for metacarpal heads and carpal bones. MagneVu MRI and CR detected 100% and 89%, respectively, of large erosions (Outcome Measures in Rheumatoid Arthritis Clinical Trials-Rheumatoid Arthritis MRI Scoring System (OMERACT-RAMRIS) score >1 on Artoscan) in MCP joints and 69% and 15.8% of large erosions in wrists.
CONCLUSIONS: Both E-MRI units detected more erosions than CR, in particular due to a higher sensitivity in metacarpal heads and carpal bones. The MagneVu unit detected fewer erosions than the Artoscan unit due to a lower average image quality and a smaller proportion of bones being visualised.

Entities:  

Mesh:

Year:  2007        PMID: 17984195     DOI: 10.1136/ard.2007.076026

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  8 in total

1.  [Magnetic resonance imaging in rheumatology].

Authors:  H Kellner; W Kellner
Journal:  Z Rheumatol       Date:  2011-08       Impact factor: 1.372

Review 2.  The impact of MRI on the clinical management of inflammatory arthritides.

Authors:  Ulrich Weber; Mikkel Østergaard; Robert G W Lambert; Walter P Maksymowych
Journal:  Skeletal Radiol       Date:  2011-08-17       Impact factor: 2.199

3.  Computer-aided and manual quantifications of MRI synovitis, bone marrow edema-like lesions, erosion and cartilage loss in rheumatoid arthritis of the wrist.

Authors:  Haitao Yang; Julien Rivoire; Michael Hoppe; Waraporn Srikhum; John Imboden; Thomas M Link; Xiaojuan Li
Journal:  Skeletal Radiol       Date:  2014-12-10       Impact factor: 2.199

4.  In-office magnetic resonance imaging to monitor responses to therapy in rheumatoid arthritis.

Authors:  Norman B Gaylis; Steven D Needell
Journal:  Rheumatol Int       Date:  2009-12       Impact factor: 2.631

5.  [Low-field magnetic resonance imaging for rheumatoid arthritis].

Authors:  B Ostendorf; E Edelmann; H Kellner; A Scherer
Journal:  Z Rheumatol       Date:  2010-02       Impact factor: 1.372

6.  [Project REMISSION(PLUS): clinical and radiological remission : new treatment goals in the management of rheumatoid arthritis].

Authors:  B Ostendorf; A Scherer; H Kellner; M Backhaus
Journal:  Z Rheumatol       Date:  2008-12       Impact factor: 1.372

Review 7.  Diagnostic test accuracy of magnetic resonance imaging and ultrasound for detecting bone erosion in patients with rheumatoid arthritis.

Authors:  Haozheng Tang; Xinhua Qu; Bing Yue
Journal:  Clin Rheumatol       Date:  2019-11-12       Impact factor: 2.980

8.  Low-field magnetic resonance imaging or combined ultrasonography and anti-cyclic citrullinated peptide antibody improve correct classification of individuals as established rheumatoid arthritis: results of a population-based, cross-sectional study.

Authors:  Jens K Pedersen; Tove Lorenzen; Bo Ejbjerg; Marcin Szkudlarek; Anne Voss; Mikkel Østergaard; Anders J Svendsen; Lis S Andersen; Kim Hørslev-Petersen
Journal:  BMC Musculoskelet Disord       Date:  2014-08-07       Impact factor: 2.362

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.